Skip to content
Lower risk Drug recall · FDA · Published November 2, 2018

Sandoz Nitrofurantoin Capsules Recall: Cross Contamination Risk

Sandoz recalls 100mg Nitrofurantoin Capsules due to cross contamination risk. Affected lots expire March 2020. Consumers should contact Sandoz for details.

🇺🇸 FDA recall #D-0257-2019DrugSandoz ›
Take action

Contact the company

Recalling firmSandoz Inc100 College Rd W · Princeton, NJ 08540-6604
✎ GovInfoNow plain-language explainer

Sandoz is recalling 100mg Nitrofurantoin Capsules that may have been contaminated with other products. This could lead to unintended medication effects if taken. The recall affects specific bottle sizes and expiration dates. Read more at govinfonow.com/recall/39445-sandoz-nitrofurantoin-capsules-recall-cross-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39445-sandoz-nitrofurantoin-capsules-recall-cross-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0257-2019

Cite this page

“Sandoz Nitrofurantoin Capsules Recall: Cross Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39445-sandoz-nitrofurantoin-capsules-recall-cross-contamination-risk. Based on FDA recall #D-0257-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0257-2019%22&limit=1).

The FDA announced on 2018-11-02 that Sandoz Inc voluntarily recalled Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg due to cross-contamination with other products. The recall affects specific lots distributed nationwide in 100-capsule and 1000-capsule bottles.

How to tell if you have it

  • Brand: Sandoz
  • Product: Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg
  • NDC 0185-0122-01 (100-capsule bottles)
  • NDC 0185-0122-10 (1000-capsule bottles)
  • Lots: JB4952, JA7322, JA7324
  • Expiration dates: 03/2020
  • Distribution: Nationwide within the United States
  • Units affected: 14366 bottles

The hazard

The recall was initiated because of cross-contamination with other products. The FDA classified this as a Class III recall, indicating it is not likely to cause adverse health reactions but violates labeling or manufacturing standards.

Context

GovInfoNow's records show Sandoz Inc has 29 other recalls on record since 2013-10-09. Recent Sandoz recalls include Focalin XR 5mg Capsules (2026-06-01), Cyclophosphamide Injection (2025-09-05), and Ciprofloxacin Otic Suspension (2025-08-13). Other recent recalls of similar products include Appco Pharma Prazosin Capsules Recall (2026-03-27), Glenmark Nebivolol Tablets Recall (2025-11-18), and Asclemed Duloxetine Capsules Recall (2026-05-14).

How to tell if you have this one

Check for 100-capsule bottles (NDC 0185-0122-01) or 1000-capsule bottles (NDC 0185-0122-10) with expiration dates of March 2020.

  • Brand
    Sandoz
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Status
    Terminated
  • Distribution
    Nationwide within the United States
Recall numberProduct, codes & lotsQuantityClassNDC
D-0257-2019Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540; Lots: a) JB4952, JA7322 Exp. 03/2020; b) JA7324, Exp.03/202014366 bottlesClass III0185-0122-01, 0185-0122-10
D-0258-2019Isosorbide Dinitrate Tablets, USP 20 mg, 100-count bottles, Rx Only, Distributed by: Sandoz Inc. Princeton, NJ 08540; NDC 0781-1695-01; Lots: a) JA9535 Exp. 05/2021.18,832 bottlesClass II0781-1635-10, 0781-1635-01, 0781-1635-13, 0781-1556-01, 0781-1556-05, 0781-1556-10, 0781-1556-13, 0781-1695-13, 0781-1695-10, 0781-1695-01
D-0259-2019Isosorbide Dinitrate Tablets, USP 5 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-223-00; Lot #: HZ7896, Exp. 05/20217817 bottlesClass II—
D-0260-2019Isosorbide Dinitrate Tablets, USP 10 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-225-00; Lot #: JA3077, Exp. 05/20215100 bottlesClass II—
D-0261-2019Isosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-222-00; Lot #: JA9534, Exp. 05/20211550 bottlesClass II—
D-0262-2019Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, 100-count bottoles, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141 Manufactured by: Sandoz Inc. Princeton, NJ 08540,NDC 16714-439-01; Lot #: JA7319, JA 7320, JA7321, Exp. 03/202023053 bottlesClass III—
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC codes 0185-0122-01 or 0185-0122-10 on the bottle with an expiration date of March 2020.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Nov 2, 201812. FDA classified it Class III: Nov 20, 201823. Published in FDA’s Enforcement Report: Nov 21, 201834. FDA terminated the recall: Oct 2, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0257-2019 (November 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0257-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA